Clinical and Neurological Changes in Children with Down Syndrome Based on The Cytogenetic Profile

Main Article Content

Saodatkhon Mukhamadkhanovna Salikhova
Yakutkhon Nabiyevna Madjidova

Abstract

Down syndrome is the most common chromosomal pathology. It occurs when another chromosome appears in the 21st pair as a result of a random mutation. Often, children with Down syndrome (DS) and related disorders have some neurological problems, severe forms of stereotyped behavior. The purpose of this article was to study the neurological conditions of children with DS. Clinical, neurological, studies were performed in 120 children (75 boys, 45 girls) with DS. It was found that in children with trisomy, neurological deficits in the form of speech disorders, fine motor skills of the hand, disorders of the coordination sphere and autonomic dysregulation are more severe than in children with mosaic and translocation types.

Article Details

How to Cite
Saodatkhon Mukhamadkhanovna Salikhova, & Yakutkhon Nabiyevna Madjidova. (2021). Clinical and Neurological Changes in Children with Down Syndrome Based on The Cytogenetic Profile. International Journal of Medical Science and Clinical Research Studies, 1(7), 197–200. https://doi.org/10.47191/ijmscrs/v1-i7-07
Section
Articles

References

I. Madjidova Ya.N., Salikhova S.M.: Possible pathogenetic mechanisms of progression and the occurrence of intellectual and cognitive impairment in patients with Down syndrome, International Journal of Psychosocial and Rehabilitation, Scopus. Vol.24, special issue 1, 2020. 789-793.

II. Uryadnitskaya Natalia Anatolyevna / Down's Syndrome: Features of Neuroanatomy / Journal “Down Syndrome. XXI century ", No. 1 (8) 2012y

III. Gorianova A.B., Semenova N.A. Assessment of the pace of psychomotor development in children with Down syndrome. // Bulletin of the Russian State Medical University. Special issue. - 2013.-№1, p.311.

IV. Kashina-Yarmak V.L., A.V. Corn. Comorbid conditions in children with Down syndrome: problematic issues of medical and psychological observation and rehabilitation (literature review and own research) // ISSN 26637553. Ukraine 6 (102) / 2019.

V. Babayan V.V., Vinogradov A.F. The health status of children with Down syndrome. // Russian Bulletin of Perinatology and Pediatrics. 1: 24-8. 2013 g.

VI. Barashnev Yu.I. Down Syndrome. Medical-genetic and socio-psychological portrait. Moscow: TriadaX: 280. (ed.) 2007

VII. Grigoriev K.I., Vykhristyuk O.F. and others. Down syndrome and comorbidity: programmatic goals in the work of a doctor; pediatrician with such children. Difficult patient. 1-2: 64-70. 2017

VIII. Medvedeva T.P. The development of cognitive activity in children with Down syndrome. // A guide for parents. Moscow: 80.2007.

IX. Neizhko L.Yu., Odinokova G.Yu. and other Features of neurosonography in infants with Down syndrome. Difficult patient. 8-9; 16: 45-8. https://doi.org/10.24411/2074-1995-2018-10008. 2018

X. Odinokova G.Yu. Communication between a mother and a young child with Down syndrome: // monograph. Moscow: Polygraph service: 210.201611. E.V. 11. Pole Down Syndrome. Facts: A Guide for Parents. // Moscow: Downside Up Charitable Foundation: 36. 2009.

XI. Semenova N.A., Chubarova A.I. Physical development of children of the first year of life with Down syndrome who are fostering in a family. Questions of modern pediatrics. 11 (4): 128-132. https://doi.org/10.15690/vsp.v11i4.371. 2012

XII. Stolyarova E.I., Shamro E.V. Formation of motor and communication skills in young children with Down syndrome. // St. Petersburg: LEMA: 101.2018

XIII. Uryadnitskaya N.A. Down syndrome: features of neuroanatomy. Down syndrome XXI century. 1: 10-3. 2012

XIV. Tsvetkov V.O., Novolodskaya N.A. et al. An integrated approach to the socialization of families with children with Down syndrome. // Children's and adolescent rehabilitation. 2: 16-21. 2010

XV. Baumer N, Davidson E.J. Supporting a happy, healthy adolescence for young people with Down syndrome and other intellectual disabilities: recommendations for clinicians. Current opinion in pediatrics. 26;4: 428–34.

https://doi.org/10.1097/MOP.0000000000000122; PMid:25010137. 2014у.

XVI. De la Torre R, de Sola S, Hernandez G, et. al.: Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomizes, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15: pp. 801-810.

XVII. Van Gameren-Oosterom HBM, Fekkes M, van Wouwe JP, et. al.: Problem behavior of individuals with Down syndrome in a nationwide cohort assessed in late adolescence. J Pediatr 2013; 163: pp. 1396-1401.

XVIII. Verstegen RHJ, Chang KJJ, Kusters MAA. Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatr Allergy Immunol. 2020 Feb;31(2):117-123.

doi: 10.1111/pai.13133. Epub 2019 Oct 25.